HCPCS Level IIdrugActive
J2021
Inj, linezolid (hospira)
BETOS: O1E
Effective: 2024-07-01
Description
Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Linezolid
Manufacturer
Pfizer Inc
HCPCS Dosage
200 MG
Billing Units
3.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.